The latest market price trends of Trelagliptin and price differences across different channels

Trelagliptin (trade name: Trelagliptin) is a new type of DPP-4 inhibitor. It is mainly used to treat type 2 diabetes. It works by prolonging insulin secretion and lowering blood sugar levels. Trelagliptin succinate has been launched as a domestic drug in China, but it has not yet been included in the medical insurance system, so patients need to purchase it at their own expense. The price of the domestically produced version available in China is relatively high, but the specific costs vary by region and pharmacy.

In overseas markets, the Japanese version of the original research troagliptin has been launched, with each box selling for about more than 1,000 yuan. As an original drug, the Japanese version of troagliptin has advantages in quality control and clinical verification, so the price is relatively high. For patients who pursue drug safety and original research protection, Japanese version drugs are the main choice, but the cost burden is heavier.

At the same time, various generic versions of troagliptin are also available in overseas markets, such as the Lao version and the Bangladeshi version of troagliptin. The price of the Lao version of the generic version of trotagliptin ranges from approximately RMB 100 to RMB 600. The ingredients of the drug are basically the same as those of the original drug, which can meet the medication needs of patients to a certain extent and significantly reduce the economic burden. However, since drug quality and regulatory standards may differ between different channels, patients need to choose formal and reliable channels when purchasing to ensure drug quality and medication safety.

Generally speaking, the price difference of trotagliptin in domestic and foreign markets is large. Compared with domestically produced drugs and overseas generic drugs, the price of domestically produced drugs is more competitive, but the lack of medical insurance coverage is still a constraint. When choosing a purchasing channel, patients should comprehensively consider drug price, quality assurance and legality, and formulate a rational medication plan based on doctor's recommendations to not only ensure the treatment effect, but also control the economic burden.

Reference link:https://www.drugs.com